Xilio Therapeutics Inc.

NASDAQ: XLO · Real-Time Price · USD
0.70
-0.00 (-0.38%)
At close: Aug 15, 2025, 3:59 PM
0.70
-0.74%
After-hours: Aug 15, 2025, 06:54 PM EDT

Xilio Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.88 -0.2 -0.84 -5.89
PEG Ratio
0.01 0.02 -0.05 -0.17
PS Ratio
8.06 n/a n/a n/a
PB Ratio
2.90 0.41 0.70 2.36
P/FCF Ratio
-2.78 -218.83 -0.95 -5.35
P/OCF Ratio
-2.78 -0.22 -0.97 -5.42
OCF/S Ratio
-2.9 n/a n/a n/a
Debt / Equity Ratio
0.46 0.31 0.19 0.11
Quick Ratio
2.21 3.02 5.89 15.85
Current Ratio
2.21 3.02 5.89 15.85
Asset Turnover
0.09 n/a n/a n/a
Interest Coverage
n/a n/a n/a -125.07
Return on Equity
-3.31 -2.07 -0.83 -0.4
Return on Assets
-0.82 -1.25 -0.63 -0.34
Return on Invested Capital
-1.35 -1.64 -0.7 -0.36
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 n/a n/a n/a
Net Profit Margin
-9.18 n/a n/a n/a
Pretax Profit Margin
-9.18 n/a n/a n/a
Operating Profit Margin
-9.55 n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-9.14 n/a n/a n/a